| P2093 | author name string | Yabin Wang | |
| | Ling Tao | |
| | Hanzhong Wang | |
| | Hui Hu | |
| | Liying Chen | |
| | Jihong Yang | |
| P2860 | cites work | Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice | Q80894167 |
| | Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 |
| | Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 |
| | A major outbreak of severe acute respiratory syndrome in Hong Kong | Q33347382 |
| | In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model. | Q33639596 |
| | Aetiology: Koch's postulates fulfilled for SARS virus | Q34197103 |
| | Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice | Q34326453 |
| | Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. | Q34757587 |
| | SARS--beginning to understand a new virus | Q35701656 |
| | Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice | Q35946863 |
| | Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers | Q37015285 |
| | Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus | Q37423250 |
| | Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine | Q40484005 |
| | Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies | Q41146574 |
| | Bovine interleukins 2 and 4 expressed in recombinant bovine herpesvirus 1 are biologically active secreted glycoproteins | Q41171882 |
| | Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids | Q42981116 |
| | Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice | Q43032831 |
| | DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus | Q43564549 |
| | Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine | Q43571642 |
| | Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model | Q44183717 |
| | A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. | Q44222584 |
| | Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP. | Q44668479 |
| | Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. | Q45756366 |
| | DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. | Q46079207 |
| | Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates | Q46957936 |
| | Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. | Q47429170 |
| | Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein | Q47850103 |
| | Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation | Q72989725 |
| | Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo | Q73669406 |
| | Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants | Q73745107 |
| | Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF | Q77452199 |
| | Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression | Q78256506 |
| P433 | issue | 11 | |
| P921 | main subject | viral nucleocapsid | Q4384107 |
| | interleukins | Q194908 |
| | SARSr-CoV | Q278567 |
| | SARS-CoV-1 | Q85438966 |
| P304 | page(s) | 1685-1693 | |
| P577 | publication date | 2009-07-05 | |
| P1433 | published in | Biotechnology Letters | Q4915332 |
| P1476 | title | Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice | |
| P478 | volume | 31 | |